A new study has revealed that daily oral antiretrovirals, like Truvada, are highly effective at preventing HIV when taken consistently alongside regular medical check-ups but their efficacy ...
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...
The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.
Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Courtney ...
The incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir compared with daily oral emtricitabine-tenofovir disoproxil fumarate.
A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...
A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the virus.
Hosted on MSN5d
HIV gamechanger: Lenacapavir study participant explainsFOX 5 spoke exclusively with a participant in a study for a new injectable drug to prevent HIV. Emory University medical ...
Twice-yearly injectables might soon be available to help prevent HIV infection. The injectable Sunlenca is even more ...
A twice-yearly shot could end AIDS, but will it reach everyone who needs it? Gilead's HIV prevention drug is 100% effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback